ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 43 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $70,897 | -66.9% | 11,380 | -64.5% | 0.00% | -100.0% |
| Q3 2022 | $214,000 | +63.4% | 32,013 | +54.9% | 0.00% | 0.0% |
| Q2 2022 | $131,000 | +274.3% | 20,671 | +1199.2% | 0.00% | – |
| Q4 2015 | $35,000 | +169.2% | 1,591 | +195.2% | 0.00% | – |
| Q3 2015 | $13,000 | -86.7% | 539 | -55.2% | 0.00% | – |
| Q2 2015 | $98,000 | -60.6% | 1,202 | -55.2% | 0.00% | -100.0% |
| Q1 2015 | $249,000 | +215.2% | 2,686 | +38.0% | 0.00% | – |
| Q4 2014 | $79,000 | +68.1% | 1,946 | 0.0% | 0.00% | – |
| Q3 2014 | $47,000 | +6.8% | 1,946 | -30.5% | 0.00% | – |
| Q2 2014 | $44,000 | -25.4% | 2,800 | -28.8% | 0.00% | – |
| Q1 2014 | $59,000 | +268.8% | 3,935 | +246.7% | 0.00% | – |
| Q4 2013 | $16,000 | -94.2% | 1,135 | -92.3% | 0.00% | -100.0% |
| Q3 2013 | $278,000 | – | 14,765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
| Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
| Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
| BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
| Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
| PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
| Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
| Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
| Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
| SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |